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A case of benign acute childhood
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Abstract
Benign acute childhood myositis (BACM) is a rare transient con-
dition usually occurring at the early convalescent phase of a viral
upper respiratory tract illness, normally inﬂuenza A, and, more
frequently, inﬂuenza B infection. It is characterized by acute-
onset difﬁculty in walking as a result of severe bilateral calf pain
and by elevated muscle enzymes including creatinine kinase. It is
self-limiting because there is rapid full recovery usually within
1 week. We describe the ﬁrst case of BACM in association with
the new pandemic inﬂuenza A (H1N1) virus infection in an 11-
year-old boy from Cyprus. The child had the typical clinical and
laboratory characteristics of this clinical syndrome. Prompt diag-
nosis of this clinical entity is essential to prevent unnecessary
investigations and therapeutic interventions and to reassure the
patient and parents of the excellent prognosis.
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Benign acute childhood myositis (BACM) is a rare, self-
limiting muscle disorder mainly affecting boys of school age.
Clinically, it is characterized by the sudden onset of calf pain
and muscle tenderness, and a refusal to walk and/or difﬁculty
in walking. Serum creatinine kinase (CK) is elevated in most
cases. The clinical manifestations usually follow the initial
phase of an acute upper respiratory tract illness, most
frequently associated with inﬂuenza viruses, particularly
inﬂuenza B. Therefore, most of the cases reported in the
literature have been encountered during epidemics of
inﬂuenza [1–4]. Typically, the illness lasts for brief periods of
time, usually up to 1 week, and adults are very rarely
affected [5].
During the current pandemic of inﬂuenza A (H1N1) virus
infection, various complications have been described in chil-
dren and adults, including bacterial superinfections and neu-
rological complications [6–9]. In one report of hospitalized
cases with serious pneumonia and respiratory failure from
Mexico, increased CK serum levels were detected in 62% of
patients [10]. However, there have been no reported cases
with the clinical syndrome of benign acute myositis associ-
ated with the new inﬂuenza A virus in children.
We present a case of BACM associated with the new
inﬂuenza A (H1N1) virus infection in an 11-year-old boy
from Cyprus. To the best of our knowledge, this is the ﬁrst
case of this clinical syndrome being reported in association
with the current inﬂuenza A pandemic.
On 5 September 2009, a previously healthy 11-year-old
boy was admitted to the Special Ward for inﬂuenza A infec-
tion of the Paediatric Department of the Archbishop Makari-
os Hospital, the main referral hospital in Nicosia, the capital
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of Cyprus, because of an inability to walk. The child was pre-
viously ill with inﬂuenza-like illness (i.e. with fever, productive
cough and malaise) for which he visited the inﬂuenza clinic of
a district hospital where respiratory samples (nasopharyngeal
and pharyngeal swabs) were sent for inﬂuenza A (H1N1)
virus detection. No oseltamivir treatment was given because
it was not considered necessary. The 8-year-old sibling of
the patient was previously found to be positive for the virus.
The patient had a previous history of asthma of mild to med-
ium severity for which he occasionally received steroids and
bronchodilators, administered by inhalation. The fever sub-
sided 24 h after the visit to the district hospital and the
patient felt better.
The respiratory samples were found to be positive for
inﬂuenza A (H1N1) virus as tested by RT-PCR with virus-
speciﬁc primers at the Virus Reference Laboratory, Nicosia
General Hospital.
The next day, the patient developed severe calf pain in
both legs and an inability to walk. The child was referred to
our hospital. On admission, he was afebrile and his level of
consciousness was normal. Physical examination revealed
normal muscle power and tone, and his tendon reﬂexes and
sensation in the upper and lower extremities were also nor-
mal. However, he could not walk and there was tenderness
on palpation of the gastrocnemius muscles; no oedema,
erythema or warmth were noted.
Initial laboratory investigations revealed an increased CK
level of 6943 U/L. He also had elevated lactate dehydroge-
nase and aspartate aminotransferase levels and leucopenia
with mild neutropenia and lymphopenia (Table 1).
His erythrocyte sedimentation rate was 2 mm/h and C-
reactive protein was negative. His serum creatinine (0.6 mg/
dL) was within normal values. An echocardiogram revealed
normal anatomy and cardiac function. A urinary analysis did
not show myoglobin in urine.
One day after admission, his ability to walk had dramati-
cally improved. He could walk and run.
His CK levels gradually dropped and the child was dis-
charged 2 days after admission. One week later, a repeat
measurement revealed normal CK levels. A follow-up
telephone communication with the parents 2 weeks after
discharge revealed a full resolution of the symptoms. An
examination by the paediatric neurologist 1 month after dis-
charge was also arranged.
BACM is a rare clinical syndrome frequently associated
with the early convalescent period of inﬂuenza A and, more
frequently, inﬂuenza B infections [1,4]. More rarely, however,
some other viral agents such as the rotavirus, parainﬂuenza
type 2 and adenovirus, and Mycoplasma pneumoniae have
been implicated in the process [11–13].
BACM was ﬁrst described in 1957 by Lundberg in a series
of 74 patients, mostly children, during a large inﬂuenza out-
break and this syndrome was differentiated from the diffuse
myalgias that are a frequent symptom during the course of
inﬂuenza infection [5]. In our case, the disorder was associ-
ated with the new inﬂuenza A (H1N1) virus infection.
As indicated by animal studies, the pathogenesis of the
clinical syndrome BACM is possibly related to direct invasion
of the muscle tissue by the infecting virus and its subsequent
inability to replicate within the myocytes. The initial infection
caused some muscle ﬁbre necrosis sufﬁcient to result in the
elevation of the creatinine kinase, although no viruses could
be found in biopsy specimens, suggesting that the virus is
unable to replicate in the tissue [14]. However, in some
cases, inﬂuenza virus antigens were detected in muscle biop-
sies from patients, suggesting that these viruses can directly
infect the muscle [15]. Therefore, uncertainty remains as to
whether the myositis is caused by a direct viral action or by
immune-mediated mechanisms [3].
For reasons still unknown, BACM has been observed more
frequently in boys [4]. The clinical picture is usually very char-
acteristic: the syndrome is usually preceded by inﬂuenza, with
upper respiratory symptoms such as fever, malaise, cough,
sore throat and rhinorrhoea. The clinical manifestations that
follow are of sudden onset and mainly affect the gastrocnemius
and soleus muscles, with intense bilateral pain and tenderness
in the calf area of both legs and an inability to walk or difﬁculty
in walking. The CK is consistently elevated in almost all of the
cases [1–3,16]. There is a spontaneous resolution of all symp-
toms and recovery is rapid, usually within 1 week [3,17]. Our
case was a typical case with respect to clinical manifestations
and the patient recovered within 48 h. Myoglobin in the urine
was not reported among cases of BACM described in the liter-
ature because it supports the diagnosis of rhabdomyolysis,
which is a different entity [18]. The urinalysis in our case did
not show myoglobin. Leucopenia has also been described in
many cases during BACM and could be a ﬁnding related to the
TABLE 1. Laboratory ﬁndings, from disease onset to
follow-up
CK
(60–300
U/L)
LDH
(260–600
U/L)
ALT
(3–37
U/L)
AST
(17–59
U/L)
WBC
· 109/L
Day 1 6943 882 47 198 2.98
Day 2 5189 911 65 228 2.34
Day 3 2512 908 82 205 2.74
Day 10 289 531 53 55 3.34
Normal ranges are given in parenthesis. ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CK, creatine phosphokinase; LDH, lactate dehydro-
genase; WBC, white blood cell count.
194 Clinical Microbiology and Infection, Volume 16 Number 2, February 2010 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 179–199
preceding viral illness [2,3]. Leucopenia has also been a ﬁnding
in cases during the current pandemic of inﬂuenza A (H1N1)
infection [8–10]. Our patient had leucopenia with mild neutro-
penia and lymphopenia.
The disease is self-limiting and, when the myositis devel-
ops, the patient is already at the early convalescent phase of
the viral illness. Therefore, antivirals are not usually indi-
cated. Only supportive treatment and follow-up aiming to
monitor full recovery of the patient are required [17]. In our
case, the patient was already afebrile at the time of admis-
sion and he recovered fully in less than 48 h.
BACM is an acute, self-limiting condition with an excellent
prognosis, which occurs during the acute convalescent phase
of viral illnesses, mainly inﬂuenza A and inﬂuenza B infec-
tions, and requires no therapeutic intervention. Correct diag-
nosis by considering the characteristic clinical and laboratory
ﬁndings as well as the history of the preceding viral illness
can prevent unnecessary diagnostic procedures and reassure
both the parents and the patient of the excellent prognosis.
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Spontaneous pneumomediastinum compli-
cating pneumonia in children infected with
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Abstract
We report two occurrences of spontaneous pneumomediasti-
num (SPM) complicating pneumonia in Japanese children infected
with the novel inﬂuenza A (H1N1) virus (IV). General practitio-
ners especially should suspect possible SPM when examining and
treating children with the novel inﬂuenza accompanied by status
asthmaticus or wheezing. The presented patients illustrate the
speciﬁc clinical and radiological signs associated with SPM
complicating pneumonia in children infected with A(HINI)v.
Keywords: A (H1N1) virus, children, inﬂuenza, pneumonia,
spontaneous pneumomediastinum
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